| Page Name
|
First edit
|
Last edit
|
Edit count
|
User count
|
| ABB/Questions and Case Studies
|
2023-03-14
|
2023-03-14
|
3
|
1
|
| ABR / Questions and case studies
|
2022-02-19
|
2022-02-20
|
10
|
2
|
| ABR/Questions and Case Studies page
|
2022-12-16
|
2024-01-16
|
6
|
2
|
| Acid-Base balance
|
2022-02-19
|
2023-10-02
|
7
|
3
|
| Acid-base balance disorders
|
2022-04-04
|
2022-04-09
|
13
|
2
|
| Acidosis (signpost)
|
2023-03-12
|
2023-03-13
|
10
|
2
|
| Acute Phase Reactants
|
2020-11-08
|
2020-11-08
|
2
|
1
|
| Acute phase reactants
|
2022-02-13
|
2024-01-01
|
3
|
2
|
| Advance glycation products
|
2022-04-13
|
2024-01-10
|
3
|
3
|
| Advanced glycation products
|
2021-12-16
|
2024-02-07
|
18
|
4
|
| Aging of the organism
|
2022-12-02
|
2024-01-10
|
3
|
3
|
| Alarmin
|
2022-10-31
|
2022-10-31
|
1
|
1
|
| Alkalosis
|
2020-11-21
|
2024-03-18
|
4
|
3
|
| Alkalosis (signpost)
|
2023-03-12
|
2023-03-13
|
4
|
2
|
| Alkaptonuria
|
2012-12-05
|
2024-03-18
|
4
|
3
|
| Amino acid metabolism
|
2022-07-05
|
2022-07-05
|
1
|
1
|
| Ammonia
|
2022-02-19
|
2023-03-18
|
8
|
3
|
| Anticancer therapy
|
2020-11-09
|
2020-11-09
|
1
|
1
|
| Antioxidant protection of the human body
|
2022-02-19
|
2024-05-02
|
8
|
3
|
| Antitumor therapy
|
2022-11-05
|
2022-11-05
|
2
|
2
|
| Apoptosis
|
2023-03-19
|
2023-04-21
|
7
|
3
|
| Basic reactive forms of oxygen and nitrogen
|
2022-04-13
|
2023-10-02
|
5
|
3
|
| Bilirubin - Questions and Casuistry
|
2021-12-07
|
2023-11-10
|
85
|
3
|
| Biochemical Diagnosis of Myocardial Infarction
|
2020-11-09
|
2024-01-15
|
22
|
2
|
| Biochemical examination for patient with diabetes mellitus
|
2021-12-27
|
2024-01-15
|
55
|
3
|
| Biochemical examination in hyperlipoproteinemia
|
2021-12-02
|
2023-11-10
|
22
|
6
|
| Biochemical examination of the pancreas
|
2021-12-09
|
2021-12-22
|
94
|
2
|
| Biochemical examinations in acute myocardial infarction
|
2022-02-23
|
2024-01-15
|
3
|
2
|
| Biochemical indicators of acute myocardial infarction
|
2023-03-09
|
2023-11-10
|
6
|
2
|
| Biology of tumor growth
|
2022-02-13
|
2024-02-07
|
4
|
3
|
| C-reactive protein
|
2022-02-18
|
2023-11-19
|
4
|
3
|
| Calcium phosphate metabolism
|
2022-02-22
|
2023-11-24
|
7
|
2
|
| Carbohydrate coefficient transferrin
|
2022-02-22
|
2024-01-10
|
4
|
2
|
| Carbohydrate deficient transferrin
|
2021-12-10
|
2023-05-15
|
5
|
3
|
| Carbohydrates in food
|
2023-02-04
|
2024-01-05
|
2
|
2
|
| Carbohydrates in the diet
|
2021-12-25
|
2021-12-25
|
3
|
1
|
| Carbon monoxide intoxication
|
2022-02-22
|
2022-02-22
|
3
|
1
|
| Carcinogenicity of Substances and Factors in the Environment
|
2011-11-21
|
2014-12-08
|
23
|
4
|
| Caspases
|
2022-02-22
|
2022-11-17
|
9
|
2
|
| Causes of pathological conformation of proteins
|
2008-11-22
|
2022-04-24
|
92
|
10
|
| Cerebral-induced salt loss syndrome
|
2023-04-04
|
2023-11-24
|
2
|
2
|
| Chaperones
|
2022-02-20
|
2023-11-19
|
5
|
3
|
| Combined disorders of acid-base balance
|
2020-11-13
|
2023-11-10
|
6
|
3
|
| Congenital adrenal hyperplasia
|
2022-02-22
|
2023-11-22
|
9
|
2
|
| Congenital disorders of glycosylation
|
2023-03-13
|
2023-04-09
|
5
|
3
|
| Congenital disorders of phenylalanine metabolism
|
2023-03-11
|
2023-06-22
|
13
|
3
|
| Congenital glycosylation disorders
|
2022-04-07
|
2023-12-21
|
5
|
3
|
| Correction and compensation of acid-base balance disorders
|
2023-01-01
|
2023-01-03
|
6
|
2
|
| Correction and compensation of acid-base imbalances
|
2022-02-22
|
2022-02-22
|
4
|
1
|
| Cretenismus
|
2022-02-22
|
2022-02-22
|
4
|
1
|
| Cretinism
|
2020-11-28
|
2020-11-29
|
4
|
1
|
| Crigler-Najjar syndrome
|
2021-12-13
|
2023-11-10
|
5
|
2
|
| Cytochrome P450
|
2022-02-20
|
2024-04-16
|
12
|
3
|
| Cytostatics
|
2021-12-08
|
2021-12-08
|
6
|
1
|
| DNA Methylation
|
2022-06-03
|
2022-06-03
|
2
|
1
|
| Diabetes insipidus
|
2022-02-16
|
2024-01-14
|
4
|
4
|
| Diabetes mellitus
|
2022-04-05
|
2024-01-14
|
7
|
2
|
| Diabetes mellitus type 1 (biochemistry)
|
2022-12-11
|
2022-12-13
|
7
|
2
|
| Difference between average and maximum lifespan
|
2023-03-09
|
2023-03-16
|
5
|
2
|
| Disorders of Calcium And Phosphate Metabolism
|
2022-12-20
|
2024-01-15
|
7
|
3
|
| Disorders of DNA repair mechanisms in tumor cells
|
2022-02-20
|
2024-01-15
|
3
|
2
|
| Disorders of Purine and Pyrimidine metabolism
|
2023-03-08
|
2023-03-16
|
7
|
3
|
| Disorders of acid-base balance
|
2022-12-16
|
2023-03-14
|
3
|
2
|
| Disorders of aromatic and branched chain amino acid metabolism
|
2022-04-04
|
2024-01-15
|
5
|
3
|
| Disorders of cobalamin metabolism
|
2022-04-04
|
2024-01-15
|
4
|
3
|
| Disorders of creatine synthesis
|
2022-04-17
|
2024-01-15
|
8
|
3
|
| Disorders of folate metabolism
|
2022-04-04
|
2024-01-15
|
4
|
3
|
| Disorders of fructose metabolism
|
2022-04-04
|
2024-01-15
|
5
|
3
|
| Disorders of galactose metabolism
|
2022-04-04
|
2024-01-15
|
4
|
3
|
| Disorders of glucose metabolism
|
2022-04-04
|
2024-01-15
|
8
|
4
|
| Disorders of glucose metabolism/Questions and case studies
|
2023-03-18
|
2023-03-20
|
3
|
2
|
| Disorders of iron metabolism
|
2022-12-16
|
2024-04-25
|
2
|
2
|
| Disorders of lipid metabolism
|
2020-11-07
|
2021-12-23
|
19
|
4
|
| Disorders of lipid metabolism (detailed)
|
2021-12-29
|
2021-12-30
|
15
|
2
|
| Disorders of lipid metabolism/Questions and case studies
|
2023-03-18
|
2023-04-19
|
8
|
2
|
| Disorders of lysosomal metabolism / Deficiency of enzyme activators of lysosomal hydrolases
|
2022-02-26
|
2022-02-26
|
4
|
1
|
| Disorders of lysosomal metabolism / Lysosomal hydrolase deficiency
|
2022-04-08
|
2024-01-15
|
34
|
3
|
| Disorders of lysosome metabolism/Lysosomal hydrolase deficiency
|
2023-04-05
|
2023-04-05
|
3
|
2
|
| Disorders of purine metabolism
|
2022-04-04
|
2024-01-15
|
5
|
4
|
| Disorders of pyrimidine metabolism
|
2022-05-01
|
2024-01-15
|
4
|
2
|
| Disorders of uric acid metabolism
|
2022-04-05
|
2024-02-06
|
7
|
4
|
| Disorders of uric acid metabolism / Questions and case reports
|
2021-12-30
|
2021-12-31
|
13
|
2
|
| Disorders of uric acid metabolism/Questions and case studies
|
2023-03-18
|
2023-03-20
|
4
|
2
|
| Disorders of water metabolism
|
2023-03-26
|
2024-01-15
|
13
|
2
|
| Disturbances in water management in the body
|
2022-04-17
|
2024-01-15
|
10
|
3
|
| Dysbalance natria (pediatrics)
|
2022-04-04
|
2022-04-26
|
3
|
2
|
| Dysbetalipoproteinemia
|
2022-04-04
|
2024-01-15
|
3
|
3
|
| Dysbetalipoproteinemie
|
2022-04-09
|
2023-11-10
|
4
|
2
|
| Dyslipidemia
|
2022-02-04
|
2024-01-15
|
5
|
2
|
| Dysproteinemia
|
2021-12-05
|
2024-01-15
|
3
|
2
|
| Eating Disorders: Questions and Case studies
|
2022-07-25
|
2024-01-15
|
9
|
2
|
| Eating disorders.
|
2022-04-09
|
2023-11-10
|
8
|
2
|
| Eicosanoids/Questions and case reports
|
2022-12-21
|
2022-12-21
|
2
|
1
|
| Elements of signal transduction as therapeutic targets in oncology
|
2022-11-20
|
2022-11-25
|
9
|
2
|
| Energy metabolism and disorders
|
2022-02-20
|
2024-01-15
|
7
|
3
|
| Epithelia (pathobiochemistry)
|
2022-11-30
|
2024-01-15
|
12
|
3
|
| Epithelium (Pathobiochemistry)
|
2022-02-20
|
2022-02-20
|
7
|
2
|
| Ethanol
|
2022-04-04
|
2024-01-10
|
6
|
4
|
| Examination for thyroid diseases
|
2022-02-05
|
2022-02-12
|
6
|
2
|
| Examination methods in DMP
|
2022-04-10
|
2023-11-22
|
11
|
2
|
| Examination methods of inherited metabolic disorders
|
2022-04-07
|
2023-11-24
|
7
|
2
|
| Examination of antioxidant capacity parameters
|
2022-04-06
|
2022-04-06
|
4
|
1
|
| Examination of concentration ability of the kidneys
|
2022-07-07
|
2022-07-07
|
2
|
1
|
| Examination of the concentrating ability of the kidneys
|
2022-11-25
|
2022-12-17
|
4
|
2
|
| Examination of urinary sediment
|
2021-12-15
|
2023-11-10
|
17
|
2
|
| Excitotoxicity in the pathogenesis of CNS disorders
|
2021-01-18
|
2023-04-05
|
8
|
3
|
| Fabry Disease
|
2023-03-27
|
2023-11-22
|
35
|
4
|
| Fats in diet
|
2020-11-24
|
2022-05-15
|
12
|
3
|
| Fructose metabolism
|
2022-11-25
|
2024-01-23
|
3
|
3
|
| Galactitol
|
2022-04-05
|
2022-04-09
|
3
|
2
|
| Gene expression disorders/Questions and case studies
|
2023-03-18
|
2023-03-20
|
4
|
2
|
| Germ cells
|
2022-04-13
|
2022-04-13
|
5
|
1
|
| Glucose in the urine
|
2023-03-09
|
2023-05-14
|
8
|
3
|
| Glucose metabolism disorders
|
2023-04-10
|
2024-01-21
|
2
|
2
|
| Glucose-6-phosphate dehydrogenase deficiency
|
2021-12-12
|
2023-11-10
|
25
|
4
|
| Glycemia
|
2022-02-20
|
2024-01-13
|
4
|
3
|
| Glycogenosis
|
2022-02-20
|
2024-01-16
|
6
|
3
|
| Glycogenosis / Questions and case reports
|
2021-12-15
|
2024-01-16
|
13
|
3
|
| Glycogenosis / question and case reports
|
2022-02-24
|
2024-01-16
|
3
|
3
|
| Glycogenosis/ Classification and basic characteristics of glycogenoses
|
2022-02-21
|
2024-01-16
|
3
|
3
|
| Glycoproteinoses
|
2023-03-23
|
2023-03-26
|
4
|
2
|
| Glycoproteinosis
|
2022-02-20
|
2024-01-16
|
3
|
2
|
| Hereditary disorders of amino acid metabolism / Questions and case reports
|
2021-12-14
|
2022-02-28
|
5
|
2
|
| Hereditary disorders of amino acid metabolism/Questions and case studies
|
2023-03-14
|
2023-06-14
|
17
|
2
|
| Hereditary disorders of sugar metabolism
|
2022-04-15
|
2023-11-22
|
4
|
3
|
| Hereditary metabolic disorders / Bone marrow and organ transplantation, gene therapy
|
2022-04-15
|
2022-04-26
|
5
|
2
|
| Hereditary metabolic disorders / Pathogenetic mechanisms
|
2022-04-15
|
2022-04-26
|
4
|
2
|
| Hereditary metabolic disorders / Treatment of diseases caused by disorders of amino acid and carbohydrate metabolism
|
2022-04-13
|
2023-11-24
|
8
|
2
|
| Hereditary metabolic disorders of complex molecules
|
2023-04-03
|
2023-11-24
|
13
|
3
|
| Hereditary metabolic disorders/Genetic background
|
2023-03-09
|
2023-11-24
|
6
|
3
|
| Hyperammonemia
|
2022-02-24
|
2023-04-10
|
6
|
2
|
| Hyperkapnia
|
2023-05-26
|
2023-05-26
|
1
|
1
|
| Hypernatremia (pediatrics)
|
2022-02-23
|
2022-02-28
|
11
|
1
|
| Hyperstenuria
|
2022-02-24
|
2023-03-17
|
7
|
3
|
| Hypocapnea
|
2022-02-24
|
2023-10-02
|
6
|
3
|
| Hypochloraemia
|
2022-02-22
|
2024-02-04
|
6
|
3
|
| Hypochloremia
|
2023-01-01
|
2023-04-08
|
13
|
3
|
| Hypokalemia
|
2023-01-01
|
2023-11-22
|
7
|
3
|
| Hypokapnia
|
2023-05-26
|
2023-05-28
|
2
|
2
|
| Hyponatremia (pediatrics)
|
2022-02-23
|
2024-05-03
|
2
|
2
|
| Hypophosphatemia
|
2022-02-22
|
2024-05-03
|
3
|
2
|
| Indoor environment (pediatrics)
|
2022-07-07
|
2023-11-24
|
6
|
2
|
| Internal environment (pediatrics)
|
2022-04-07
|
2023-11-19
|
3
|
3
|
| Intoxication
|
2022-02-21
|
2022-02-22
|
6
|
1
|
| Investigation of antioxidant capacity parameters
|
2022-12-09
|
2022-12-30
|
6
|
2
|
| Investigation of the metabolism of porphyrins
|
2022-07-05
|
2022-07-05
|
1
|
1
|
| Isoenzymes
|
2022-02-22
|
2022-02-22
|
3
|
1
|
| Isostenuria
|
2022-02-22
|
2022-02-22
|
3
|
1
|
| Isosthenuria
|
2023-01-06
|
2023-10-02
|
4
|
3
|
| Isovaleric aciduria
|
2022-02-22
|
2022-02-22
|
8
|
1
|
| Keto bodies
|
2022-12-20
|
2023-01-04
|
10
|
1
|
| Ketoacidosis (FBLT)
|
2022-02-22
|
2023-10-02
|
13
|
3
|
| Ketones
|
2022-02-22
|
2022-11-17
|
9
|
2
|
| Krabbe disease
|
2022-02-22
|
2023-11-08
|
6
|
2
|
| LCHAD deficiency
|
2022-04-04
|
2022-04-09
|
4
|
2
|
| LRO
|
2022-12-20
|
2023-01-04
|
2
|
2
|
| Laboratory testing of cellular immunity
|
2022-02-25
|
2024-04-26
|
5
|
2
|
| Lactate dehydrogenase
|
2022-02-25
|
2024-04-26
|
5
|
3
|
| Leucinosis
|
2022-02-25
|
2022-02-28
|
3
|
1
|
| Lipid peroxidation
|
2022-07-05
|
2022-07-05
|
1
|
1
|
| Lipidoses
|
2023-03-29
|
2023-04-30
|
26
|
5
|
| Lipidosis
|
2022-02-25
|
2022-02-28
|
11
|
1
|
| Lysosomal Diseases
|
2023-04-29
|
2023-05-06
|
32
|
2
|
| Lysosome-related organelles
|
2022-02-25
|
2022-02-26
|
5
|
2
|
| Lysosomes
|
2022-02-25
|
2022-02-26
|
4
|
3
|
| MTOR a inhibitory mTOR
|
2022-12-22
|
2022-12-23
|
17
|
2
|
| Mechanism of action of poisons
|
2022-11-25
|
2022-11-25
|
3
|
1
|
| Mechanism of poisoning
|
2022-02-26
|
2024-01-25
|
5
|
3
|
| Mechanisms of cancer development
|
2021-12-15
|
2023-11-10
|
20
|
3
|
| Mechanisms of maintenance of acid-base balance
|
2023-01-04
|
2023-01-04
|
3
|
2
|
| Mechanisms of tumor formation
|
2022-02-18
|
2022-02-18
|
3
|
1
|
| Mediators of inflammation, Alarmins
|
2022-11-14
|
2022-11-30
|
2
|
2
|
| Metabolic syndrome and insulin resistance
|
2022-02-25
|
2024-01-17
|
8
|
2
|
| Methemoglobin
|
2022-06-03
|
2023-05-26
|
14
|
2
|
| Methotrexate
|
2020-11-29
|
2022-11-27
|
7
|
3
|
| Mitochondrial disease
|
2023-05-12
|
2023-11-24
|
3
|
2
|
| Mitochondrial diseases / Respiratory chain enzyme deficiency
|
2022-02-27
|
2024-01-23
|
9
|
2
|
| Molecular mechanisms of metastasis
|
2022-02-28
|
2022-02-28
|
5
|
1
|
| Molecular-biological Diagnostics in Oncology
|
2022-02-18
|
2022-02-19
|
11
|
2
|
| Monitoring of the internal environment in intensive care
|
2022-02-11
|
2023-01-04
|
45
|
4
|
| Mucopolysaccharidosis
|
2022-02-28
|
2022-03-02
|
6
|
2
|
| Mucopolysaccharidosis II. type
|
2022-02-28
|
2022-02-28
|
9
|
1
|
| Mucopolysaccharidosis III. type
|
2022-02-28
|
2022-03-02
|
7
|
2
|
| Mucopolysaccharidosis IV. type
|
2022-02-28
|
2022-02-28
|
5
|
1
|
| Mutator genes, cell genome stability
|
2022-02-19
|
2022-02-19
|
3
|
1
|
| Mutator genes, stability of the cell genome
|
2023-02-10
|
2023-02-10
|
1
|
1
|
| Myopathy
|
2021-12-19
|
2023-11-10
|
9
|
3
|
| Myxedema
|
2022-12-19
|
2023-11-22
|
4
|
2
|
| NO-synthase
|
2022-03-01
|
2023-05-14
|
4
|
3
|
| Natriuretic peptides
|
2022-03-01
|
2023-10-02
|
6
|
3
|
| Neovascularization
|
2022-01-04
|
2022-03-20
|
9
|
1
|
| Newborn screening
|
2022-03-01
|
2023-11-22
|
4
|
4
|
| Nutritional disorders
|
2023-03-17
|
2023-04-09
|
6
|
2
|
| Nutritional disorders / Questions and case reports
|
2022-01-06
|
2022-02-16
|
12
|
3
|
| Options for minimal residual disease detection
|
2023-02-10
|
2023-02-10
|
1
|
1
|
| P53
|
2022-02-20
|
2022-02-20
|
3
|
1
|
| Parameters of liver synthetic function
|
2022-07-05
|
2022-07-05
|
1
|
1
|
| Paraproteinemia
|
2022-01-06
|
2022-09-11
|
5
|
3
|
| Pb intoxication
|
2014-03-04
|
2014-12-08
|
10
|
4
|
| Phenylketonuria
|
2021-01-28
|
2022-04-05
|
9
|
3
|
| Phenylketonuria (PKU)
|
2022-04-11
|
2022-04-13
|
4
|
2
|
| Porphyria
|
2022-01-04
|
2022-02-17
|
4
|
2
|
| Porphyria / Questions and case studies
|
2022-01-06
|
2022-02-18
|
18
|
3
|
| Possibilities of detection of minimal residual disease
|
2021-01-12
|
2021-01-12
|
1
|
1
|
| Primary mixed hyperlipidemia
|
2022-04-09
|
2022-04-09
|
7
|
1
|
| Principles of therapy of hereditary diseases
|
2022-04-09
|
2023-11-10
|
7
|
4
|
| Principles of treatment of acid-base balance disorders
|
2022-04-09
|
2023-11-10
|
7
|
2
|
| Prion
|
2012-02-02
|
2024-01-13
|
8
|
3
|
| Procalcitonin
|
2021-12-16
|
2023-03-17
|
22
|
5
|
| Proteins in food
|
2022-12-21
|
2024-04-25
|
2
|
2
|
| Proteins in serum and urine (1. LF UK, VL)
|
2022-12-10
|
2023-11-10
|
4
|
2
|
| Relationships between acid-base balance and ionogram
|
2022-04-12
|
2022-04-28
|
6
|
2
|
| Reoxidative and reperfusion tissue damage
|
2022-04-09
|
2022-04-09
|
2
|
1
|
| STAT laboratory tests
|
2022-11-23
|
2022-12-10
|
11
|
2
|
| Selected biochemical examinations in patients with diabetes mellitus (1st Faculty of Medicine, Charles University, VL, 2nd year)
|
2023-05-01
|
2023-05-03
|
21
|
2
|
| Sideropenic anemia
|
2022-11-12
|
2023-11-19
|
10
|
4
|
| Sodium
|
2022-03-01
|
2023-10-02
|
5
|
4
|
| Sodium imbalance (pediatrics)
|
2023-03-09
|
2023-11-24
|
5
|
3
|
| Starvation and disorders of ketone body production
|
2022-02-23
|
2023-05-16
|
3
|
2
|
| Stem cells
|
2022-02-22
|
2022-02-22
|
4
|
1
|
| TNF
|
2022-02-05
|
2022-08-06
|
5
|
4
|
| The importance of mitochondria in cell death and aging
|
2022-04-13
|
2022-04-13
|
3
|
1
|
| Thiamine pyrophosphate
|
2022-04-06
|
2024-03-18
|
8
|
3
|
| Thyroid disease examination
|
2022-12-22
|
2023-11-10
|
7
|
3
|
| Thyrotoxicosis
|
2020-11-25
|
2023-06-03
|
16
|
3
|
| Troponins
|
2022-04-06
|
2022-04-06
|
5
|
2
|
| Tumor Markers
|
2020-12-31
|
2023-04-18
|
9
|
5
|
| Tumor stroma as a therapeutic target
|
2023-02-10
|
2023-02-10
|
3
|
1
|
| Tumor suppressor gene
|
2022-07-01
|
2024-04-25
|
7
|
3
|
| Tumor suppressor genes
|
2017-06-29
|
2022-10-30
|
17
|
3
|
| Tumor trees as a therapeutic target
|
2022-02-20
|
2022-02-20
|
7
|
1
|
| Tumors with familial occurrence
|
2021-12-04
|
2022-08-06
|
9
|
3
|
| Type 1 diabetes mellitus (biochemistry)
|
2022-04-15
|
2022-04-15
|
1
|
1
|
| Type 2 diabetes mellitus (biochemistry)
|
2022-04-16
|
2022-04-16
|
3
|
1
|
| Type 2 diabetes mellitus in childhood and adolescence
|
2022-04-15
|
2023-11-19
|
3
|
2
|
| Tyrosinemia
|
2022-04-06
|
2023-11-19
|
11
|
2
|
| Urea Cycle Disorders
|
2022-01-04
|
2023-11-09
|
8
|
3
|
| Urea cycle disorders
|
2022-12-16
|
2023-11-10
|
3
|
2
|
| Vascular endothelial cells
|
2023-03-09
|
2023-03-10
|
4
|
2
|
| Viral carcinogenesis
|
2022-01-29
|
2022-10-30
|
8
|
4
|
| WHO classification of central nervous system tumors
|
2022-04-13
|
2022-04-13
|
3
|
1
|
| Wilson's disease
|
2020-12-02
|
2023-11-10
|
10
|
2
|
| Zellweger syndrome
|
2023-01-19
|
2023-11-10
|
21
|
4
|
| Portal:Pathobiochemistry
|
2009-04-19
|
2014-04-04
|
18
|
7
|
| Talk:Hereditary metabolic disorders / Pathogenetic mechanisms
|
2022-04-15
|
2022-04-15
|
2
|
1
|
| User:Deleted
|
2022-02-25
|
2022-02-27
|
12
|
5
|
| File:Symbol patobiochemie.png
|
2011-10-25
|
2014-12-08
|
2
|
2
|
